A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
Clinical trial NCT00778700 · COMPLETED
Trial details
- NCT number
- NCT00778700
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-28
- Primary completion
- 2009-06-26
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.